CryoGen

CryoGen

PRE-SALE ENDED
15,857 Views
The utility token CRYO is generated by CryoGen and provides its holders with the access to the current and future services of the company. CryoGen has embodied best technologies and 12 years of experience in the cryonics market from the first cryocompany in Eurasia - KrioRus. CRYO is an Utility token. Being not a financial instrument, it gives holders the access to Cryogen services, which can be purchased in CryoStore. The project's mission is to enable people to prolong life through application of cutting-edge science of cryonics technology.
4.4
TOTAL SCORE
4
PRODUCT

(weight: 25%)

3
BUSINESS

(weight: 25%)

5.8
ICO PROFILE

(weight: 25%)

1
TEAM PROOF

(weight: 10%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 09 Nov 2017 - 01 Feb 2018
Country: Russia
Token info
Ticker: CRYO
Token Type: ERC20
Financial
ICO Price: 1 CRYO = 1 USD
2018
The opening of the NGO CRYOGEN with the Swiss jurisdiction.
2019
Start of the mass experiments on reversible cryopreservation of animal organs.
2020
The technology of euthanasia cryonics is worked out and applied. Start of the development of technologies for reliable and effective reversible cryopreservation of the mammal organs.
2021
The technology of reliable and effective reversible cryopreservation of most mammal organs has been obtained. Experiments begin with the organs of the dying people.
2022
Anabiosis technology developing for deep space flights.
Screenshots taken on 5 Feb 2018
Valeriya Udalova
Co-founder and CEO of the Russian company "KrioRus."
No participating data
Sergey Evfratov
Head of Kriorus perfusion lab. Biochemist, a molecular biologist.
No participating data
Yuriy Pichugin
Director of Science. PhD. International experience in cryobiology is 40 years.
No participating data
Igor Artyukhov
Co-Founder and Development Director of KrioRus.
No participating data
Ustin Kolbin
Director of Communications for Project Cryogen.
No participating data

Advisors (1)

Elena Serebryannikova
A financial adviser to the Cryogen project in Switzerland.
No participating data
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Stealthcrypto
The StealthCrypto® utility token will be the native cryptocurrency of the StealthCrypto® system. Funds collected through the token sale will be used to develop as well as activate and purchase StealthCrypto Cloud® products and products in the StealthCrypto® ecosystem. The values of StealthCrypto® tokens are fully dependent upon the developments of Stealth Grid™ and market demand.
Upcoming
Ultrain
Ultrain Technology Limited is the next generation public-blockchain technology venture that focuses on building a high performance decentralized blockchain platform through its programmable tech-infrastructure. Ultrain is committed to construct a responsible and sustainable commercial ecosystem that enables all industrial applications. With its groundbreaking innovations in cryptography and based upon a complete decentralized public network, Ultrain is able to provide multi-folds more advanced technical performance to fundamentally solve the performance and scalability issues comparing to other traditional public blockchain platforms.
Upcoming
Hoard
Hoard is about to change the future of the video gaming industry by facilitating True Ownership of game assets on the blockchain. Today more and more people are selling virtual goods and services. With Hoard, all of this can be tokenized and made tradeable in a manner that is honest for all participants. We believe that Hoard will facilitate the global revolution in the Gaming Industry. Hoard offers a unique value-proposition to game makers and gamers alike; enabling real-world economies in games with true-ownership of virtual items, game-interoperability and new models of financing for the development of games.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.
Pre-Sale
2GETHER
2gether is developing the bank of the future, a future where; consumers take full ownership and control of the services they use, move beyond solely interacting with euros and dollars and fully embrace cryptocurrencies and digital assets, and augment their financial decisions through the use of exponential technologies like artificial intelligence, big data and blockchain. We are on a mission to change the way people interact with their finances. We are building a modern mutual organisation where everyone is an owner of their banking experience.
Upcoming
Little Phil
Powered by blockchain technology, the little Phil platform is an entirely new way of giving that fixes trust issues with charities using a public ledger, smart contracts and unique digital identities (UDID) to provide givers with the Proof of Need and Proof of Impact required to re-establish trust in giving to charity. Little Phil uses blockchain technology and user experience (UX) designed around a positive psychology framework to allow people to have the oversight, control and emotional connection of a philanthropist, without giving large amounts. People are able to give on their terms through their smartphone and track their giving all the way to the moment it’s received. This will create an engaging experience that makes them genuinely feel the positive impact they have had on their cause. In addition to this, charities will have solutions to their fundraising and exploitation concerns at a much lower cost than they currently incur.